Bal Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE083D01012
  • NSEID: BALPHARMA
  • BSEID: 524824
INR
95.32
2.63 (2.84%)
BSENSE

Sep 08, 11:45 AM

BSE+NSE Vol: 94.35 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryBal Pharma VS Pharmaceuticals & Biotechnology
 
1D
2.84%
-0.44%
1W
11.55%
-1.59%
1M
6.83%
-3.65%
YTD
30.01%
-9.4%
1Y
6.96%
-4.44%
3Y
-3.23%
19.44%
5Y
0.18%
36.42%
10Y
4.98%
164.43%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.29%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.09%
1.39%
13.48%
6 Months
31.53%
1.68%
33.21%
1 Year
6.96%
2.74%
9.7%
2 Years
-28.67%
1.82%
-26.85%
3 Years
-3.23%
3.77%
0.54%
4 Years
-1.83%
4.97%
3.14%
5 Years
0.18%
5.44%
5.62%

Latest dividend: 1.2 per share ex-dividend date: Sep-18-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Bal Pharma Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
16.52%
3
Quartile
quartile-3
Mar-Jun
31.66%
3
Quartile
quartile-3
Dec-Mar
-17.59%
2
Quartile
quartile-2
YTD
4.01%
3
Quartile
quartile-3
2025
-40.21%
2
Quartile
quartile-2
2024
22.56%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Underperformer

Bal Pharma Ltd has been in the Third and Fourth Quartile in the YTD and longer periods

2
Quartile
quartile-2
QTD
16.52%
2
Quartile
quartile-2
Mar-Jun
31.66%
3
Quartile
quartile-3
Dec-Mar
-17.59%
3
Quartile
quartile-3
YTD
4.01%
4
Quartile
quartile-4
2025
-40.21%
3
Quartile
quartile-3
2024
22.56%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Bal Pharma Ltd has not been a consistent performer in the YTD and longer periods

1
Quartile
quartile-1
QTD
16.52%
2
Quartile
quartile-2
Mar-Jun
31.66%
2
Quartile
quartile-2
Dec-Mar
-17.59%
2
Quartile
quartile-2
YTD
4.01%
4
Quartile
quartile-4
2025
-40.21%
2
Quartile
quartile-2
2024
22.56%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available